Dirui Industrial Co Ltd
Dirui Industrial Co., Ltd. engages in the research and development, production, and sale of medical inspection products in the People's Republic of China. The company provides medical instruments and supporting test strip reagents. It also offers urine and biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and integrat… Read more
Dirui Industrial Co Ltd (300396) - Net Assets
Latest net assets as of September 2025: CN¥1.90 Billion CNY
Based on the latest financial reports, Dirui Industrial Co Ltd (300396) has net assets worth CN¥1.90 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.78 Billion) and total liabilities (CN¥889.04 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.90 Billion |
| % of Total Assets | 68.08% |
| Annual Growth Rate | 22.51% |
| 5-Year Change | 23.83% |
| 10-Year Change | 59.32% |
| Growth Volatility | 35.11 |
Dirui Industrial Co Ltd - Net Assets Trend (2009–2024)
This chart illustrates how Dirui Industrial Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Dirui Industrial Co Ltd (2009–2024)
The table below shows the annual net assets of Dirui Industrial Co Ltd from 2009 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.05 Billion | +0.46% |
| 2023-12-31 | CN¥2.04 Billion | +6.22% |
| 2022-12-31 | CN¥1.92 Billion | +2.32% |
| 2021-12-31 | CN¥1.88 Billion | +13.41% |
| 2020-12-31 | CN¥1.65 Billion | -4.63% |
| 2019-12-31 | CN¥1.73 Billion | +11.04% |
| 2018-12-31 | CN¥1.56 Billion | +10.46% |
| 2017-12-31 | CN¥1.41 Billion | +2.78% |
| 2016-12-31 | CN¥1.38 Billion | +7.01% |
| 2015-12-31 | CN¥1.29 Billion | +39.80% |
| 2014-12-31 | CN¥919.82 Million | +130.49% |
| 2013-12-31 | CN¥399.08 Million | +18.83% |
| 2012-12-31 | CN¥335.83 Million | +33.47% |
| 2011-12-31 | CN¥251.61 Million | +43.53% |
| 2010-12-31 | CN¥175.30 Million | +79.89% |
| 2009-12-31 | CN¥97.44 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Dirui Industrial Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2487.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.35 Billion | 66.13% |
| Common Stock | CN¥272.70 Million | 13.31% |
| Other Comprehensive Income | CN¥178.44 Million | 8.71% |
| Other Components | CN¥242.72 Million | 11.85% |
| Total Equity | CN¥2.05 Billion | 100.00% |
Dirui Industrial Co Ltd Competitors by Market Cap
The table below lists competitors of Dirui Industrial Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Praram 9 Hospital Public Company Limited
BK:PR9
|
$222.26 Million |
|
SK Chemicals Co Ltd Pref
KO:28513K
|
$222.37 Million |
|
Hefei Hengxin Life Science and Technology Co., Ltd.
SHE:301501
|
$222.41 Million |
|
China Building Material
SHG:603060
|
$222.42 Million |
|
Malteries Franco-Belges Société Anonyme
PA:MALT
|
$222.25 Million |
|
CHINA YOUZAN LTD. HD-01
F:YSZ
|
$222.15 Million |
|
Bold Eagle Acquisition Corp. Class A Ordinary Shares
NASDAQ:BEAG
|
$222.13 Million |
|
Clarity Pharmaceuticals Ltd
PINK:CLRPF
|
$222.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dirui Industrial Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,039,281,003 to 2,048,756,770, a change of 9,475,767 (0.5%).
- Net income of 141,922,552 contributed positively to equity growth.
- Dividend payments of 146,303,981 reduced retained earnings.
- Share repurchases of 15,713,730 reduced equity.
- Other comprehensive income increased equity by 178,436,818.
- Other factors decreased equity by 148,865,892.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥141.92 Million | +6.93% |
| Dividends Paid | CN¥146.30 Million | -7.14% |
| Share Repurchases | CN¥15.71 Million | -0.77% |
| Other Comprehensive Income | CN¥178.44 Million | +8.71% |
| Other Changes | CN¥-148.87 Million | -7.27% |
| Total Change | CN¥- | 0.46% |
Book Value vs Market Value Analysis
This analysis compares Dirui Industrial Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.67x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 26.45x to 1.67x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | CN¥0.47 | CN¥12.52 | x |
| 2010-12-31 | CN¥0.89 | CN¥12.52 | x |
| 2011-12-31 | CN¥1.22 | CN¥12.52 | x |
| 2012-12-31 | CN¥1.62 | CN¥12.52 | x |
| 2013-12-31 | CN¥1.92 | CN¥12.52 | x |
| 2014-12-31 | CN¥4.08 | CN¥12.52 | x |
| 2015-12-31 | CN¥3.63 | CN¥12.52 | x |
| 2016-12-31 | CN¥3.96 | CN¥12.52 | x |
| 2017-12-31 | CN¥4.48 | CN¥12.52 | x |
| 2018-12-31 | CN¥5.00 | CN¥12.52 | x |
| 2019-12-31 | CN¥5.56 | CN¥12.52 | x |
| 2020-12-31 | CN¥6.04 | CN¥12.52 | x |
| 2021-12-31 | CN¥6.84 | CN¥12.52 | x |
| 2022-12-31 | CN¥6.97 | CN¥12.52 | x |
| 2023-12-31 | CN¥7.47 | CN¥12.52 | x |
| 2024-12-31 | CN¥7.51 | CN¥12.52 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dirui Industrial Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.93%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.65%
- • Asset Turnover: 0.39x
- • Equity Multiplier: 1.52x
- Recent ROE (6.93%) is below the historical average (16.95%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 20.07% | 10.65% | 1.03x | 1.82x | CN¥9.39 Million |
| 2010 | 34.45% | 26.12% | 0.99x | 1.33x | CN¥42.86 Million |
| 2011 | 30.33% | 21.31% | 0.93x | 1.53x | CN¥51.15 Million |
| 2012 | 25.08% | 20.36% | 0.84x | 1.47x | CN¥50.64 Million |
| 2013 | 23.46% | 20.16% | 0.85x | 1.37x | CN¥53.70 Million |
| 2014 | 11.02% | 20.84% | 0.46x | 1.14x | CN¥9.38 Million |
| 2015 | 10.86% | 19.09% | 0.32x | 1.77x | CN¥8.54 Million |
| 2016 | 11.46% | 16.49% | 0.41x | 1.70x | CN¥15.90 Million |
| 2017 | 13.54% | 19.29% | 0.47x | 1.50x | CN¥43.77 Million |
| 2018 | 14.32% | 21.18% | 0.47x | 1.44x | CN¥59.61 Million |
| 2019 | 15.21% | 22.99% | 0.49x | 1.35x | CN¥79.40 Million |
| 2020 | 16.14% | 28.50% | 0.46x | 1.22x | CN¥101.62 Million |
| 2021 | 11.19% | 23.18% | 0.38x | 1.27x | CN¥22.31 Million |
| 2022 | 13.64% | 21.46% | 0.42x | 1.52x | CN¥69.85 Million |
| 2023 | 13.51% | 20.21% | 0.41x | 1.63x | CN¥71.66 Million |
| 2024 | 6.93% | 11.65% | 0.39x | 1.52x | CN¥-62.95 Million |
Industry Comparison
This section compares Dirui Industrial Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dirui Industrial Co Ltd (300396) | CN¥1.90 Billion | 20.07% | 0.47x | $222.26 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |